Skip to main content

Table 2 Standard treatment of patients receiving Convalescent Plasma Therapy

From: Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series

No. Antiviral Antibiotic Corticosteroid/Other Oxygen support
Before CPT After CPT
1 Oseltamivir 2 × 75 mg (PO) Azithromycin 1 × 500 mg (PO)
Meropenem 3 × 1 g (IV)
Cefepime 2 × 1 g (IV)
Dexamethasone 1 × 2.5 mg (IV)
Tocilizumab 400 mg (IV)
NRM 15 L/min NC 4 L/minute 5 days after CPT
2 Lopinavir 2 × 2 tab (PO)
Isoprinosine 4 × 500 mg (PO)
Oseltamivir 2 × 75 mg (PO)
Azithromycin 1 × 500 mg (IV)
Levofloxacin 1 × 750 mg (IV)
Dexamethasone 3 × 5 mg (IV) Non Rebreathing Mask 15 L/minute NC 3 L/minute 3 days after CPT
3 Methisoprinol 4 × 500 mg (PO) Meropenem 3 × 1 g (IV)
Azithromycin 1 × 500 mg (PO)
Dexamethasone 2 × 5 mg (PO) Non Rebreathing Mask 15 L/minute NC 3 L/minute 1 day after CPT
4 Favipiravir 2 × 800 mg day 1 and 2 × 600 mg days 2–6 (PO)
Intravenous immunoglobuline 1 × 25 g for 5 days (IV)
Levofloxacin 1 × 500 mg (IV)
Azithromycin 1 × 500 mg (PO)
Meropenem 3 × 1 g (IV)
Dexamethasone 3 × 5 mg (PO)
Tocilizumab 400 mg (IV)
HFNC FiO2 70% flow 40 L/minute High Flow Nasal Cannula FiO2 40% flow 35 L/minute 5 days after CPT
5 Lopinavir 2 × 2 tab
Methisoprinol 3 × 1 (PO)
Favipiravir 2 × 1600 mg day 1, 2 × 600 mg day 2–5 (PO)
Levofloxacin 1 × 750 mg (IV)
Meropenem 3 × 1 g (IV)
Dexamethasone 3 × 5 mg (IV) Non Rebreathing Mask 15 lpm Room air 3 days after CPT
6 Methisoprinol 3 × 500 mg (PO)
Favipiravir 2 × 1600 mg day 1, 2 × 600 mg days 2–5 (PO)
Azithromycin 1 × 500 mg (PO) Dexamethasone 3 × 5 mg (IV) Simple mask 8 L/minute NC 3 L/minute 2 days after CPT
7 Favipiravir 2 × 600 mg (PO) Levofloxacin 1 × 750 mg (IV)
Ceftriaxone 1 × 2 g (IV)
Azithromycin 1 × 500 mg (PO)
Meropenem 3 × 1 g (IV)
Dexamethasone 1 × 2.5 mg (IV)
Tocilizumab 400 mg (IV)
NC 3 L/minute Room air 8 days after CPT
8 Favipiravir 2 × 1600 mg day 1, 2 × 600 mg days 2–5 (PO) Levofloxacin 1 × 750 mg (IV)
Meropenem 3 × 1 g (IV)
Ceftazidime 3 × 1 g (IV)
Dexamethasone 2 × 5 mg (IV) High Flow Nasal Cannula FiO2 90% flow 50 L/minute Non Rebreathing Mask 15 L/minute 6 days after CPT
  1. CPT: Convalescent plasma therapy, NC: Nasal Cannula, NRM: Non Rebreathing Mask, IV: Intravenous, PO: Peroral